The Oxford Coronavirus Vaccine Has Successfully Passed The First Phase Of Trials
A new type of coronavirus vaccine created by researchers from the University of Oxford has successfully passed the first phase of clinical trials, demonstrating signs of effectiveness and safety. This is stated in an article published on Monday by the British medical journal The Lancet by the authors of the development.
"We have received encouraging results indicating the safety of the drug," the article says. "No serious side effects were detected. Seroconversion (the process of producing antibodies by the body) was observed in more than 96% of the study participants, and neutralizing antibodies were produced in 85% of them. 90% of participants also had a T-cell response," the study authors note.